Target intelligence / Profile preview

RNA, U1 small nuclear 62, pseudogene (RNU1-62P)

Target
RNU1-62P
Molecular classification
Non-coding RNA, Pseudogene, Small nuclear RNA (snRNA)-related
01

Overview

RNA, U1 small nuclear 62, pseudogene (RNU1-62P) is a **non-coding RNA pseudogene** related to the U1 small nuclear RNA (snRNA) gene family[1][5]. While canonical U1 snRNAs are essential components of the spliceosome and play critical roles in pre-mRNA splicing, pseudogenes such as RNU1-62P are traditionally classified as nonfunctional genetic elements due to sequence modifications or truncations that prevent their normal function[4]. However, emerging research has shown that some U1 snRNA pseudogenes can be transcribed, processed, and even participate in regulatory functions influencing gene expression in specific cellular contexts[4]. There is no evidence that RNU1-62P acts as a classic drug target (e.g., receptor, enzyme, transporter), nor is it known to interact with therapeutic agents or serve as a biomarker[1][5]. It is not associated with known diseases beyond its annotation as a genomic feature, but variant U1 snRNAs from other loci have been shown to modulate splicing and RNA processing, sometimes in a developmental stage-specific manner[4].

Other names
RNU1-62PRNA, U1 small nuclear 62, pseudogene
02

Biological functions

Potential regulation of pre-mRNA processing (as observed for some U1 snRNA pseudogenes and variants)Other
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, U1 small nuclear 62, pseudogene (RNU1-62P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 62, pseudogene (RNU1-62P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call